Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Fund manager finds plenty of virtue in sin stocks
By MARK JEWELL
The Associated Press
Thursday, August 19, 2010; 6:33 PM
BOSTON -- So much for virtue. Sin is in.
That's according to a mutual fund manager who's finding plenty of investment opportunities in companies profiting from vices like smoking, drinking and gambling.
Jeff Middleswart's aptly named Vice Fund is beating the house in a down market. The Standard & Poor's 500 index is down 1.9 percent this year. Yet stocks of cigarette makers are up an average 12 percent.
The Vice Fund's three biggest holdings are cigarette stocks: Philip Morris International Inc., Lorillard Inc. and Altria Group Inc. That explains why the fund is up 4.5 percent this year, ranking in the top 3 percent of its large-blend fund peers according to Morningstar.
Defense contractors - another fund mainstay - are up an average 12 percent. Some group contractors in this category because their profits are tied to the escalation of conflicts. Alcoholic beverages? Up 6 percent.
Vice is the lifeblood of a fund that's a counterpoint to investment products touting themselves as socially responsible because they favor companies ostensibly benefiting society. This year, those stocks aren't doing anything special. An index of socially responsible stocks, the MSCI USA Large Cap ESG, is down 1.7 percent.
Vice Fund (VICEX) is rebounding from lagging returns in 2008 and 2009. Its turnaround would be even bigger if not for the average 30 percent decline for stocks of gaming companies. They're struggling to cut hefty debt loads, a legacy from years of casino-building.
Vice is the only fund explicitly focusing on sin stocks. Its portfolio of about 30 stocks is divided almost equally among cigarettes, alcohol, gaming and casinos, and defense - industries that typically hold up well in tough times. Although such a small portfolio can lead to volatility, the Vice Fund offsets that risk by emphasizing steady dividend-paying stocks.
Middleswart replaced previous manager Charles Norton in February, after more than two decades as an investment analyst. The 40-year-old Dallas resident manages the eight-year-old fund for USA Mutual Funds, along with the smaller Generation Wave Growth Fund (GWGFX), which invests in stocks expected to profit from spending by baby boomers. Both were founded by Dan Ahrens, who left in 2005 after writing a book that explained his investment thesis. Its title: "Investing in Vice: The Recession-Proof Portfolio of Booze, Bets, Bombs, and Butts."
Here are excerpts from a recent interview with Middleswart about the Vice fund, and this year's standout performance for many sin stocks:
Q: Were you at all reluctant to manage the fund because of its focus on sin stocks?
A: Not at all. I've always been a contrarian, and I've always looked for deep value stocks. If you listed everything you look for in a stock - companies with growing cash flow, that pay dividends and buy back shares and have clean balance sheets - you'd find a huge list of sin stocks.
Yet people look at them and say, "I don't want to own that, it's tobacco, it's an industry that's going out of business." Or they say, "I don't want to own an alcohol stock."
These are stocks with the (financial) characteristics everybody says they want, and we're getting them at a discount. That's because certain people don't want to own them.
Q: Is there anything unique about the types of investors drawn to the Vice fund?
A: For the most part, they're individual investors. We have a higher-than-average percentage of people in the military who own the fund.
Q: Your top holding, at about 12 percent of the fund's assets, is Philip Morris. What do you find attractive about one of the world's largest tobacco companies?
A: Philip Morris has international tobacco exposure, which is still growing. In emerging markets, people are smoking more, and they're going for brand name cigarettes. With this stock, you're getting a dividend yield of nearly 5 percent, and they also have enough cash flow to buy back shares.
You've got a company that doesn't have to spend a fortune every year remaking itself, in terms of research and development, and signing new distribution agreements.
Q: Another one of your favorites is Anheuser-Busch InBev SA, the product of a 2008 deal pairing U.S. and Belgian brewers. What do you like about the stock?
A: The company is paying down debt rapidly, and it has solid cash flow growth. The way they're going, they'll eventually start rewarding shareholders with a bigger dividend, perhaps in the 5 to 6 percent range. It's also got a big presence in growing markets like Brazil. I think the stock will have a decent pop over the next year and a half, and at that point it will become a cash machine for shareholders.
Q: Why have you cut back on gaming stocks?
A: Because gaming companies hold so much debt, and their U.S. growth prospects are limited. You've got lots of city and state governments saying they want to get into gaming in a bigger way. So they're authorizing new casinos. But that's essentially dividing up the same dollars. As you divide the pot among more players, you will see a lower return.
Q: Your fund owns stocks in two makers of game terminals: Bally Technologies Inc. and International Game Technology. Why do you prefer these to casino stocks?
A: As long as casinos expand, they'll have to buy new slot machines and video lottery terminals. These companies will benefit. They don't have a ton of debt the way many casinos do.
Also, the casinos in Las Vegas used to be on a 4- to 5-year replacement cycle for new machines. But because of all the debt troubles they had in 2008 and 2009, a lot of those replacements have been postponed. There's a lot of pent-up demand.
Q: Do you spend your free time buying the stuff sin stocks peddle?
A: I will have a glass of wine or drink a beer, but my gambling mostly consists of a couple days a year at the horse track. I'm more likely to go hiking or run on the treadmill than anything else.
------
Sin stocks: One reason it's good to buy bad
Dividends of sin beat the wages any day, as Vice Fund generates solid return
By Jeff Benjamin
July 13, 2010 1:12 pm ET
Dividend yields are starting to make sin stocks difficult to ignore, according to Jeff Middleswart, manager of the Vice Fund (VICEX).
With the exception of the gambling sector, the other three of the big four sin stock categories – tobacco, alcohol and defense – are providing steady total returns in an otherwise iffy market environment.
While some investors and portfolio managers pride themselves in avoiding so-called sin stocks, Mr. Middleswart prefers to tap into the dividends being thrown off by a lot of these companies.
Mr. Middleswart took over management of the $67 million fund offered by USA Mutuals in February.
In general, he said, tobacco stocks are paying dividends in the 5% to 6% range, defense stocks are paying nearly 3.5%, and alcohol sector stocks are paying around 3%.
“These companies have to do something with the cash flow,” he said.
The gambling industry, in general, is still struggling to recover from a slower economy and weaker balance sheets.
“We're looking for stocks that are trading cheaper than the market and with lots of free cash flow,” Mr. Middleswart said. “We end up picking up a greater dividend yield than the market as a whole and that gives us a built-in fairly solid 8% or 9% return.”
The reason many sin stocks do so well in more difficult economies often boils down to cash flow, which can translate to dividends and stock buy-back programs.
“These companies don't spend a lot of money on research and development, they're not remaking products all the time, they mostly control their own distribution, they have lean cost structures, and consumers buy the products in good times and bad,” Mr. Middleswart said.
The sin stock categories are also shielded from the threat of new competitors because of the high barriers to entry.
And consolidation has further bolstered the industries.
Liquor producers, for example, have shrunk from 20 major players a decade ago to a field of just eight today.
In the defense sector, more than 20 years of consolidation has resulted in a half-dozen major companies and a lot of subcontractors.
“These defense companies are supported by a lot of long-term government contracts, and it's tough for startups to get government contracts,” Mr. Middleswart said.
The Vice Fund typically holds about three dozen stocks, and has an annual turnover rate of about 30%.
Some of the stocks he likes in each of the four broad categories include Anheuser-Busch InBev (BUD), Lorillard Inc. (LO), General Dynamics Corp. (GD), and Churchill Downs Inc. (CHDN).
Portfolio Manager Perspectives are regular interviews with some of the most respected and influential fund managers in the investment industry. For more information, please visit InvestmentNews.com/pmperspectives.
You should join me on these alc bev stock boards.
I am moderator on many here.
I watch DEO, ROX, CEDC, BF, STZ, LIQR, MLMN, AWGL, BLVI, LVMUY, PDRDY and ICNB.
Hey there
how ya doing?
I see FO pretty low now and DKAM looking about to pinch
Where have you been hiding girl?
Southern Gaming Casino summit had some interesting things going on this past week...
MLMN is doing some interesting things.
Bloomberg: Berkshire to Buy Alcohol Distributor in U.S. South (Update1)
March 22, 2010, 6:24 PM EDT
By Andrew Frye
March 22 (Bloomberg) -- Warren Buffett’s Berkshire Hathaway Inc. agreed to buy alcoholic-beverage distributor Kahn Ventures Inc. to add sales in Georgia and North Carolina and help the company prepare for further acquisitions in the industry.
Closely held Kahn, owner of Empire Distributors, will be part of Omaha, Nebraska-based Berkshire’s McLane unit, Buffett’s company said today in a statement. Terms weren’t disclosed.
“We expect that the Empire acquisition will provide us with a solid platform for potentially acquiring other similar high-quality wholesale distributors,” Buffett, Berkshire’s chairman and chief executive officer, said in the statement.
McLane already accounts for more than a quarter of Berkshire’s revenue, with sales to grocery stores, retailers and chain restaurants. Berkshire was a shareholder of Anheuser-Busch Cos. before the brewer of Budweiser beer was bought by InBev NV.
Buffett, 79, completed the biggest takeover of his career last month with the $27 billion acquisition of railroad Burlington Northern Santa Fe Corp.
--Editors: Dan Reichl, Erik Holm
To contact the reporter on this story: Andrew Frye in New York at afrye@bloomberg.net
To contact the editor responsible for this story: Dan Kraut at dkraut2@bloomberg.net
Newsweek reporter Tara Kalwarski inverviewed C.J. Eiras, CEO of Liquor Group (LIQR) for their article this week on the alcohol industry overall.
www.NewsWeek.com
Big news in PA gaming. Anybody own PA gaming stocks?
Casino Gaming Summit coming up in May:
www.SGSummit.com
It will be interesting to see what the gaming industry thinks about the upcoming economy.
Vice Vice Baby...VICEX looking like a smart play with all these terrorist attacks, people drinking and smoking more, just have to get them gambling...legally gambling that is!
Interesting article on Alcohol Consumption Worldwide:
http://www.morssglobalfinance.com/drinking-patterns-global-and-local/
Listen to NASDAQ Vice Fund (MUTF:VICEX) Conference:
http://www.investorcalendar.com/IC/CEPage.asp?ID=152884
Just got turned on to this board!
VICEX (NASDAQ:VICE) has their annual conference call this Wednesday 3:30 EST.
From their press release:
For additional information, please call 1-866-264-8783 to speak with a USA Mutuals support representative or email info@usamutuals.com.
Sinful Mutual fund (curtesy of alien_IQ
VICEX http://www.vicefund.com/vicefund/abt.aspx
AEROSPACE/DEFENSE · GAMING · TOBACCO · ALCOHOLIC BEVERAGES
These four sectors were chosen because they demonstrate one or more of these compelling and distinctive investment characteristics:
* Steady demand regardless of economic condition
* Global Marketplace - not limited to the U.S. economy
* Potentially high profit margins
* Natural barriers to new competition
We believe that there are numerous investment opportunities in these sectors which have been largely overlooked by other funds. While many of the most widely held and well-known mutual fund families invest in companies doing business in these industries, no other fund concentrates solely on these four sectors.
Our rigorous focus on aerospace/defense, gaming, tobacco and alcoholic beverages has given us experience navigating within them, and provides our investors with maximum exposure to these sectors.
The Vice Fund
Minimum Investment:$2,000.
Minimun Additional: $100.
Sales Load: NONE
Inception Date: 8/30/2002
Ticker Symbol: VICEX
Objective: Long-term growth of capital.
Advisor: Mutuals Advisors, Inc
DAAT update -- Q1 2009 earnings out:
"30% Increase in Revenue and 339% Increase in Net Income"
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=37844890
Q1 EPS +.03, Trailing 4Q earnings = +.086/share. Book value = .89/share.
Trailing PE of 15 = $1.29/share, Trailing PE of 20 = $1.72/share
Annualized PE of 15 = $1.80/share, Annualized PE of 20 = $2.40/share
Company has a history of aggressively buying back shares since Sept, an amount equal to 4% of the current outstanding shares.
Cost inputs have been going down for higher profits going forward.
DAAT = debt-free, very profitable, undervalued, sexy story with the company historically aggressively buying back shares in the open market.
Gun sales have gone through the roof which is helping DAAT since they sell gun locks, cases, and cleaning kits.
"Gun sales spike amid fears of federal regulation"
http://www.mlive.com/news/chronicle/index.ssf?/base/news-16/1233919064211400.xml&coll=8
"Obama Driving Surge in Gun Sales, Firearms Groups Say
End-of-the-year statistics show background checks for firearms purchases rose sharply in the last three months of 2008."
http://www.foxnews.com/politics/2009/01/16/firearms-associations-claim-obama-drove-surge-gun-sales/
MORE DAAT DD & INFO & MESSAGE BOARD:
http://investorshub.advfn.com/boards/board.aspx?board_id=3270
hey jscot
that would be great to post on the panic board as well:
http://investorshub.advfn.com/boards/board.aspx?board_id=10093
we should add a section for "market meltdown" as well!
Resistance to flu drug widespread in U.S.: study
http://news.yahoo.com/s/nm/20090302/ts_nm/us_flu_tamiflu
GlaxoSmithKline, which makes the rival flu drug Relenza, said there was no indication influenza viruses were resistant to its drug. Relenza, known generically as zanamivir, is squirted into the nose and is used even less commonly than Tamiflu.
I knew I was opposite than most lol
Really? that makes most hyper
LOL heck, Benadryl knocks me out even!
well when you start taking meds for it let me know so I can buy stock in that company :P
that's odd you posted that
haven't slept in 3 nights lol
With the Economy Down, Sleeplessness Is Up
http://news.yahoo.com/s/hsn/20090302/hl_hsn/withtheeconomydownsleeplessnessisup
Health care, defense poised to weather recession
Saturday November 1, 12:31 pm ET
By Matthew Perrone, AP Business Writer
Health care and defense sectors will weather recession, but analysts say future is hazy
WASHINGTON (AP) -- With the global economy at risk of a deep recession, many battered areas of the economy stand to suffer more damage in coming months. Other industries, though, seem poised to withstand even a severe downturn.
The health care sector should hold up especially well even in a recession, along with defense and a few other industries. Still, analysts say a unique collision of economic and political challenges means many businesses might not be as well-insulated as they were in past recessions. Here's a look at major industries that, if not exactly recession-proof, seem best able to endure the downturn:
--Health care
With an aging population and the largest health care spending in the world, the nation's medical sector could fare perhaps best of all. During economic downturns, sales of prescription drugs and medical devices tend to hold up better than nonessential goods, noted David Wyss, chief economist of Standard and Poor's.
"Generally, you're looking for things that are necessities, not luxuries," Wyss said. "People get sick and need medical care regardless of the state of the economy."
But recent earnings show that drug makers aren't immune from slumping sales that have plagued their peers in the retail and auto industries. Pfizer said last month that U.S. sales of its best-selling product, the cholesterol drug Lipitor, fell 13 percent in the last quarter as some financially struggling patients stopped filling their prescriptions.
"The typical safe harbors (for investors) have been pharmaceuticals," said analyst Steve Brozak of WBB Securities. "They're no longer safe; they're now the least bad choice."
Pfizer and Schering-Plough Corp. were able to offset weak revenue in the U.S. with higher sales abroad. But other companies, such as Merck & Co. Inc., have been less successful. Merck said recently it will cut 7,200 jobs after reporting sales declines.
Experts say pharmaceuticals are more vulnerable to economic cycles because employers have shifted more of the financial burden for care to patients, with higher copays and deductibles.
"With consumers having more cost-sharing in their benefits, you're going to see a greater effect on their health care spending right away," said Paul Ginsburg, President of the nonprofit Center for Studying Health System Change.
The lagging economy and rising unemployment have made it harder for health insurers such as UnitedHealth Group Inc. and Humana Inc. to raise prices to offset higher costs and investment losses.
Health care companies least affected are those that sell inexpensive medical products directly to hospitals, bypassing cash-strapped consumers.
Becton, Dickinson & Co. and Baxter International Inc., for example, reported sharp profit gains for the most recent quarter and boosted their full-year earnings estimates. Becton Dickinson specializes in syringes and surgical tools; Baxter sells drugs to treat blood and immune disorders.
"The products they offer aren't high-tech things," said Aaron Vaughn, an analyst with Edward Jones. "They are health care staples that people need."
A focus on lifesaving medicine is also expected to reward makers of high-priced biotechnology drugs. Genzyme Corp. and Celgene Corp., for example, have built businesses around niche drugs for life-threatening diseases. Health care investment firm Leerink Swann gives both companies an "outperform" rating, along with peers Amgen Inc., Biogen Idec Inc. and Gilead Sciences Inc.
--Defense
With the government spending hundreds of billions of dollars to fight wars in Iraq and Afghanistan, most big defense-related companies should also be able to withstand recessionary pressures.
Military spending has soared about 40 percent during the Bush administration, pushing up the stocks of General Dynamics Corp. and its competitors. The company's chief executive, Nicholas Chabraja, has pointed to General Dynamic's backlog of orders -- totaling $60.5 billion at the end of the quarter -- as a sign of the company's long-term strength.
Rivals such as Northrop Grumman Corp. and Lockheed Martin Corp. also have contracts that stretch decades into the future, as well as large cash reserves.
Analysts caution, though, that long-term problems loom for the sector. Both presidential candidates have called for reforms on how defense contracts are awarded, and many analysts see the government's $700 billion bailout plan as a crimp on future spending.
It seems "nearly impossible" that future military budgets "will remain unscathed by the current fiscal reality," Ronald Epstein, a Merrill Lynch analyst, wrote in a recent note.
JSA Research analyst Paul Nisbet said that even a partial withdrawal from Iraq would hurt ammunition manufacturers such as Alliant Techsystems Inc. and General Dynamics. Democratic candidate Barack Obama has also expressed skepticism about the level of spending on missile defense -- a revenue generator for Raytheon Co. and Boeing Co.
By contrast, Nisbet said companies such as Boeing and Goodrich Corp. are better positioned to weather defense cuts because much of their business involves the private aviation market.
--Food and consumer staples
While health insurers and defense contractors are subject to policy changes in Washington, other sectors are more stable. Food companies such as Kraft Foods Inc. and Kellogg Co. tend to perform fairly consistently, even during tough times, which is why their stocks are holding up well, analysts say.
General Mills, maker of Cheerios and Pillsbury products, is one of the best-performing stocks in the S&P 500. Its strong brands have helped it outperform competitors for years.
As consumers begin eating at home more often, they are boosting sales at chains such as BJ's Wholesale Club Inc. that can deliver groceries at the lowest price, often at the expense of more high-end companies. Shares of Whole Foods Market Inc. have lost three-quarters of their value this year as the organic-food retailer lowered its outlook and suspended its quarterly dividend indefinitely.
At the same time, chains such as Costco Wholesale Corp. and Kroger Co. have reported rising earnings as shoppers trade down to lower-budget store brands.
--Tobacco and alcohol
Beer and cigarettes don't seem as indispensable as food and medicine, but demand for tobacco and alcohol tends to remain strong in tough economic times.
Last month, Philip Morris International Inc. and Reynolds American Inc. reported results that topped Wall Street expectations. Executives said steady sales show consumers remain loyal to tobacco products even as they cut back on other expenses.
"No business in the world is actually recession-proof, but I am convinced that our business is very recession-resilient," said Hermann Waldemer, chief financial officer of Philip Morris.
The company, which reported it had $1 billion more in cash than short-term debt in June, said it generates more than $10 billion in operating cash per year.
The beer industry has proved nearly as elastic. Its sales to retailers have risen about half a percent for the year, according to trade publication Beer Marketer's Insights. Though that's down from last year's 1.4 percent growth rate, analysts say the business is still performing relatively well.
"Vices tend to be a good place to seek shelter because people pretty much support their vices -- at least the cheaper ones," said S&P's Wynn.
AP Business Writers Stephen Manning in Washington, Emily Fredix in Milwaukee and Vinnee Tong in New York contributed to this report.
me too, thanks
hope you have a good day T :)
as are you!
you're in the right place :)
well my holy trinity anyway........
ATF!!!!!! the holy trinity! weeeeeeeeeeeeeeee
Re: is MASP ready - maybe, if it can break up through $3.80 resistance.
IS MASP READY...
InBev and Anheuser-Busch agree to merge
LEUVEN, Belgium (Thomson Financial) - InBev and Anheuser-Busch Cos Inc said
they agreed to combine the two companies, forming the world's leading global
brewer.
Anheuser-Busch shareholders will receive $70 per share in cash, for an
aggregate equity value of $52 billion. The combined company will be called
Anheuser-Busch InBev. Both companies' boards of directors have unanimously
approved the transaction.
InBev has fully committed financing for the purchase of all of
Anheuser-Busch's outstanding shares and the companies said they see cost
synergies of at least $1.5 billion by 2011, phased in equally over three years.
The transaction is expected to be neutral to normalised in terms of earnings
per-share in 2009 and accretive beginning in 2010, and return on invested
capital will exceed weighted average cost of capital during the second year
after close.
InBev CEO Carlos Brito will be chief executive officer of the combined
company, while the rest of the board will comprise the existing InBev board,
current Anheuser-Busch president and CEO August Busch IV, and one current or
former director from Anheuser-Busch's board.
tf.TFN-Europe_newsdesk@thomson.com
vs/ajb
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
Trading Chaos by Bill Williams
An excellent book on trading and on the meaning of life! The basic approach is Elliot Wave but with plenty of trading tips and ideas to keep non-Ellioticians happy. The last few chapters on the psychology of trading are fascinating: I discovered that I am an Ectomorph body type for example. Definitely worth a read.
InBev And Anheuser May Toast After All
Javier Espinoza and Miriam Marcus 07.11.08, 6:20 PM ET
LONDON -
Patriotic though it may seem, Anheuser-Busch could be cozying up to a new drinking partner in InBev. The Belgian brewer has reportedly hiked its takeover bid for the brewer of Budweiser beer by $5 a share, to $70, valuing its target at $50.8 billion, and Anheuser has also reportedly agreed to engage in friendly talks. In June, InBev launched an unsolicited $46.3 billion takeover offer, sparking animosity between the two companies.
Analysts have told Forbes.com over the past few weeks however that InBev was likely to increase the price per share of its offer, as Anheuser shareholders were trying to squeeze out a better deal.
Investors seem to think a higher bid is coming. Anheuser-Busch jumped 8.6%, or $5.29, to close at $66.50, in trading in New York, above the previous bid price. Shares in InBev rose 7.4%, or 3.05 euros ($4.85), to 44.55 euros ($70.82), in Brussels.
InBev refused to comment, and Anheuser-Busch "does not confirm, deny or speculate on rumors of potential investments, acquisitions, mergers, new business partnerships or other transactions," said W. Randolph Baker, the company's vice president and chief financial officer.
"It appears that, based on the price increase, Anheuser is willing to engage in a transaction with InBev," Morton Pierce, chief executive of Mergers & Acquisitions group, told Forbes.com.
"The price increase was intended to put pressure on Anheuser-Busch to negotiate and also generate more shareholder pressure," Pierce said.
Should the deal take place, it will rank as the largest takeover in the United States for 2008, according to Thompson Financial.
A report on the Wall Street Journal's Web site on Friday said that InBev had raised its bid for Anheuser, and cited a person familiar with the matter. It said the Anheuser-Busch board is likely to accept the offer this weekend.
That would be a stunning turnaround from the often heated rhetoric between the two companies over the past several days.
Analyst Juli Niemann of Smith Moore investment brokers agreed the merger could be announced any day. "It really is all about the money," Niemann said. "We just had to get a little bit more on the table. Bottom line is the rest is just housekeeping--what's going to be the name of the new company, that sort of thing. The layoffs will go ahead. Asset sales--you've got to pay for it."
InBev is also said to have launched a $45.0 billion syndicated loan to purchase Anheuser, according to TradeTheNews., and is asking its relationship banks for large commitments of $1.75 billion each, in return for high pricing and fees and a rapid refinancing strategy, all of which have been designed to counter tough and illiquid loan market conditions, Reuters reported.
Since InBev made its original $46.3 billion, $65-a-share bid for Anheuser in June, the two sides have not been speaking to each other, at least publicly.
Both companies have approached the courts, with the Belgian brewer looking to oust Anheuser's board and replace it with its own version that includes a member of the Busch family, while the St. Louis-based Anheuser has responded by filing suit in a U.S. federal court on Tuesday, and has also criticized InBev for having operations in Cuba.
The Associated Press and Reuters contributed to this article.
I'm liking IGT/FO/RAI/AOI/MGM/Wolf
Charts are really nice but takes too long to upload when opening the ibox.
RUNU is worth a look. Support is at .036 and looks like it could be heading up.
Up 33% today seems like the MM's are trying to hold this one back though.
Hi Cap!
I like the pattern in the RGR chart. Add some volume and this looks to me like it is ready to pop.
Taking it down again today on low volume.
Sure is CA and on low volume as well, if they decide to run this thing it can really fly.
rox looking good today BB
No problem CA, i got through with IR today and they said that no insider selling or dilution and probably is an Institution getting out since the PPS has dropped below $1 for over a month.
howdy bb money! thanks for bringing this one up.
ive gone thru and tried to find why this one is dumping butt couldn't find much...hmm?
thanks
~CA
http://finance.yahoo.com/q?s=rox&x=18&y=14
ROX
Ok, Here is a great beat up stock...It is batter and brusied and took one heck of a beating the past few days.Since going public, the stock has traded between 0.49 and 3.03 times sales. The stock is currently selling at a P/S multiple of .26 which is well below its normal range!
Out standing shares 15 million
Float 12 million
UHV the last few days on no news
RSI 20.68
Looks like it may have hit bottom today.
Last December .82 back to 3.00, it may take a little patience but should be real nice
I am in
http://stockcharts.com/h-sc/ui?s=ROX...d=p76674842647
I really really like this one, with an extremely low float and increased volume this thing is due for another breakout. Extremely undervalued at these levels it is ridiculous. This one should be real nice!
Gotta love theses ratios:
Book Value:$1.82
Cash Per Share: .51
Current Ratio: 4.35
Revenue Per Share:1.83
Followers
|
7
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
210
|
Created
|
12/29/07
|
Type
|
Free
|
Moderators BCInvestor |
NOTE: This board does NOT condone the use of any of the items that is posted here. This board however, is to monitor the trending of the stocks of companies that produce these products.
BEER STOCKS
WINE STOCKS
LIQUOR STOCKS
CASINO AND GAMING STOCKS
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |